Tony Lange

Gov. Brian Kemp signed legislation to bring the state's prohibitive low-THC medical cannabis oil program into a more permissive structure for patients.

Gov. Abigail Spanberger vetoed legislation that would have legalized a licensed marketplace with a January 2027 dispensary sales launch.

The IRS can’t dispute that medical cannabis falls outside the meaning of Schedule I or II ‘without contradicting the president, the acting attorney general and HHS,’ the company says.

The new federal posture toward loosening restrictions on cannabis does not appear to have increased congressional appetite for industry banking reform.

The Trump administration’s drug control strategy indicated enforcement of intoxicating hemp products that have largely gone unregulated.

Nebraska, Indiana and Louisiana filed a petition for review in federal court, arguing that immediately rescheduling medical cannabis violates administrative procedures.

The GOP lawmakers filed three proposed amendments to a federal appropriations bill to modify, delay or stop the ban’s forthcoming implementation.

The U.S. representatives sent a letter urging ‘clear, timely guidance’ for state-licensed medical businesses following the DOJ’s rescheduling order.

A substance abuse recovery clinic, two doctors, a victims’ advocacy organization and a pharmaceutical company claim the order was unlawful.

The state took a turn in 2026 to tighten its cannabis laws rather than loosen them, despite a Schedule III federal posture from the Trump administration.